Interrelationships between postpartum events, hormonal therapy, reproductive abnormalities and reproductive performance in dairy cows: a path analysis.
Path analysis was used to determine the interrelationships between postpartum administration of gonadotrophin releasing hormone and cloprostenol and the occurrence of reproductive disease and reproductive performance in dairy cows. The data analysed were those collected on 226 Holstein-Friesian cows calving in a commercial dairy herd during a 17 month period (May 1, 1981 to October 1, 1982). Cows administered gonadotrophin releasing hormone at day 15 postpartum experienced an improved rate of uterine involution as determined by rectal palpation nine days later. Although this improved rate of uterine involution reduced the risk of pyometritis, it actually directly delayed conception. Also, gonadotrophin releasing hormone therapy directly resulted in an increased incidence of pyometritis which in turn resulted in an increase incidence of cystic ovarian disease and anestrus. The occurrence of these abnormalities resulted in increased intervals from calving to first observed estrus, first service and conception. In addition to this effect, the administration of gonadotrophin releasing hormone was also associated with increased plasma progesterone concentrations at days 24 and 28 postpartum which delayed conception. Cloprostenol therapy at day 24 postpartum resulted in a decreased plasma progesterone concentration at day 28 postpartum which was directly and indirectly associated with a decrease in the calving to conception interval. The indirect effects were mediated by a reduction in days to first estrus. Cloprostenol therapy also directly resulted in a decreased calving to first observed estrus interval for reasons not attributable to the level of progesterone at day 28.
D000780:Anestrus; D000818:Animals; D002417:Cattle / Q000502:physiology*; D002418:Cattle Diseases; D003008:Cloprostenol / Q000494:pharmacology; D004716:Endometritis / Q000662:veterinary; D004971:Estrus; D005260:Female; D007314:Insemination; D008954:Models, Biological; D010048:Ovarian Cysts / Q000662:veterinary; D010906:Pituitary Hormone-Releasing Hormones / Q000494:pharmacology; D011247:Pregnancy; D011374:Progesterone / Q000097:blood; D011644:Puerperal Disorders / Q000662:veterinary; D012098:Reproduction / Q000187:drug effects; D013492:Suppuration / Q000662:veterinary
D010906:Pituitary Hormone-Releasing Hormones; D003008:Cloprostenol; D011374:Progesterone